Plan sponsors need to connect benefits and workplace accommodation to properly support employees with ADHD, say two group insurers
Each month at BPM, we offer a slate of articles and content pieces that go deep on a particular topic. This month, we're diving into mental health.
Despite ADHD claims climbing at double-digit rates, with younger women driving the surge, insurers suggest most private plans stop at drug reimbursement. They believe the fix lies in reassessing how employers connect benefits, workplace accommodation, and care navigation through connected models.
Sahar Rahman, VP of group insurance growth and health solutions at Ontario Teachers Insurance Plan (OTIP) in Toronto, pointed to data from OTIP’s education sector book of business that underscores just how fast demand for ADHD coverage is growing.
“Among our teachers and long-term occasional teachers, treatment increased over 20 per cent year over year in 2026. This is the fifth consecutive year in which growth exceeded 20 per cent for this group,” she said, emphasizing how female treated prevalence has more than doubled since 2022.
Medavie Blue Cross is also seeing similar trends play out in their book of business. According to Montreal-based Olivier Page, director of group disability management operations at the firm, clinicians attribute the surge to reduced stigma and greater media attention, rather than a new wave of illness.
“In 2024, we increased by 13 per cent. In 2025, we increased by approximately 11 per cent. So more than double-digit increase in terms of volume of utilization on a yearly basis for the last 2 years,” he said. “Those people had undiagnosed ADHD before and were suddenly developing the condition. It was because the prevalence was still there and rampant and people were undiagnosed.”
Where group plans fall short on ADHD coverage
According to Page, paying for drugs is only one piece of the equation and it’s the piece every insurer already covers. The biggest gap he sees is access to primary diagnosis and a continuous care treatment plan, particularly for the undiagnosed population of younger women in the workforce.
With only about two per cent of Canadians diagnosed with ADHD - well below what genetic prevalence data suggests - awareness remains a major barrier, as is cost. A private-sector ADHD assessment runs between $1,000 and $3,500, a price tag most members can’t justify, especially when they’ve built coping mechanisms that convince them they don’t need help, Page noted.
Medavie’s partnership with Beyond ADHD brings that cost down to $500, which Page believes opens the door to a far larger pool of members. But diagnosis alone isn’t enough either, he said, adding members need ongoing treatment plans, and those who turn out not to have ADHD still need to be redirected to the right professionals for anxiety or other conditions.
What’s working, he argues, is building service-based partnerships with providers who can address the gaps in access, cost, and navigation.
“We need to provide reimbursement and service and ideally navigation through those issues with the member,” he said, underscoring the goal is to keep the member’s needs at the centre and guide them to the right next step at a price and timeline that don’t become barriers in themselves.
What connected care looks like
To that end, he identifies five areas plan sponsors should focus on: lowering the cost of access, guiding care on a continuous basis, building awareness, supporting members whose needs fall outside the ADHD diagnosis, and shortening wait times that in the public system can stretch months or years.
Rahman also underscored how ADHD demands an ongoing coordinated set of support. She noted how finding credible providers is a barrier, and the condition rarely travels alone, particularly as it coexists with anxiety, depression, and other challenges that require ongoing clinical attention and medication management.
“It’s a never-ending journey,” said Rahman. “The real question is whether someone can successfully navigate from recognizing the need to receiving appropriate care. I think that's where the focus needs to be when employers think about some of these strategies.”
With demand for ADHD treatment accelerating, plan sponsors need to stop treating benefits as disconnected components and start building systems that meet members where they are – including having the right support systems in place at work, said Rahman.
“Someone with ADHD may be getting the right treatment, but they have to support. They need to manage certain challenges at work,” she said, emphasizing the clinical model has to account for the whole person. Not just their treatment plan but the workplace and daily life challenges that come with it.
From ADHD accommodation to return to work
As to what it means to properly accommodate a neurodivergent employee and how plan sponsors ensure the right accommodations are in place, Page acknowledged the legal standard is accommodation to the point of undue hardship. But that threshold varies depending on the size and situation of the business and the specific restrictions the employee faces, he noted.
The more productive approach, he argues, is to stop fixating on where the obligation ends and start collaborating with the employee on what’s possible.
“When it comes to workplace accommodation, the way here is not to find a way to exclude. It’s to find a path forward and collaborate with the employee in the realm of what’s possible for the employers to make it work,” he said.
Employers who lead with that mindset, he added, tend to land on workable strategies far more easily than those who try to define the limits of their duty first.
To that end, Page suggests the best time to accommodate is before an employee ever reaches the disability stage.
“We really think the best way to help people is to accommodate when they are in their working environment,” said Page. That’s why Medavie deployed workplace accommodation products about a year ago to help employers assess physical or mental restrictions and turn them into individualized accommodation plans that respect privacy boundaries around what an employer can request from a medical standpoint.
Should an employee go off work on a disability claim, Page underscored how the acute phase – when they’re at their most unwell and need space to stabilize – should be respected because there’s no value in overwhelming someone who needs time to stabilize, he said.
“Once they are stabilized, the real job starts. How do you create strategies - mobilization plans, rehabilitation, mental health-related tools - to make sure you have the right diagnosis, the right treatment plan, and the right level of care?” said Page.
“It could be early psychiatric access to refine a diagnosis and treatment plan, or musculoskeletal assessments to identify physical restrictions that could be supported with physiotherapy or occupational therapy sessions tailored to that individual - all mobilized in collaboration with the employer, because the employer needs to understand what type of service and support will be provided,” Page added, emphasizing a cooperative employer who supports a phased re-entry makes all the difference between a sustainable return and a relapse into leave.
Rahman agreed with Page, emphasizing how benefits, healthcare, and workplace needs can’t be treated as separate silos. For her, the accommodation question only works when all three are connected.
She pointed to OTIP’s early intervention program within its long-term disability (LTD) business as an example of that approach in practice.
“The earlier you can connect someone with the right treatment, resources, and workplace support, the better chance you have of helping them stay at work and avoid progressing to long-term disability,” she said.


